Oncocyte Corp Annual Nonoperating Income (Expense) in USD from 2014 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Oncocyte Corp quarterly/annual Nonoperating Income (Expense) history and growth rate from 2014 to 2023.
  • Oncocyte Corp Nonoperating Income (Expense) for the quarter ending June 30, 2024 was $102K.
  • Oncocyte Corp Nonoperating Income (Expense) for the twelve months ending June 30, 2024 was $451K.
  • Oncocyte Corp annual Nonoperating Income (Expense) for 2023 was $281K.
  • Oncocyte Corp annual Nonoperating Income (Expense) for 2022 was -$615K, a 172% decline from 2021.
  • Oncocyte Corp annual Nonoperating Income (Expense) for 2021 was $854K.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $281K +$896K Jan 1, 2023 Dec 31, 2023 10-K 2024-04-16
2022 -$615K -$1.47M -172% Jan 1, 2022 Dec 31, 2022 10-K 2024-04-16
2021 $854K +$2.33M Jan 1, 2021 Dec 31, 2021 10-K 2023-04-12
2020 -$1.48M -$1.29M -689% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-11
2019 -$187K +$365K +66.1% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-19
2018 -$552K -$26K -4.94% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-26
2017 -$526K -$498K -1779% Jan 1, 2017 Dec 31, 2017 10-K 2019-04-01
2016 -$28K -$11K -64.7% Jan 1, 2016 Dec 31, 2016 10-K 2018-04-02
2015 -$17K -$4K -30.8% Jan 1, 2015 Dec 31, 2015 10-K 2018-04-02
2014 -$13K Jan 1, 2014 Dec 31, 2014 10-K 2017-02-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.